KVP Capital Advisors »

Immix Biopharma shares owned by KVP Capital Advisors

Quarter-by-quarter ownership of Immix Biopharma (IMMX) shares owned by KVP Capital Advisors from 13F filings

Historical chart of KVP Capital Advisors investment in Immix Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Immix Biopharma held by KVP Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immix Biopharma by KVP Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.2M 230k 5.23

More positions owned by KVP Capital Advisors

Terns Pharmaceuticals (TERN)
Praxis Precision Medicines I Com New (PRAX)
Axsome Therapeutics (AXSM)
Jazz Pharmaceuticals Call Call Option
Aadi Bioscience (WHWK)
Trevi Therapeutics (TRVI)
Insmed Com Par $.01 (INSM)
Protagonist Therapeutics (PTGX)
Disc Medicine (IRON)
Mbx Biosciences (MBX)
Savara (SVRA)
Travere Therapeutics (TVTX)
Edgewise Therapeutics (EWTX)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)

View all positions for KVP Capital Advisors

Top funds holding Immix Biopharma

Marshall Wace
Vanguard Group
Logos Global Management
Franklin Resources
Bleichroeder
Renaissance Technologies
Geode Capital Management
KVP Capital Advisors
Goldman Sachs Group
Eudaimonia Asset Management
Bank of New York Mellon
State Street Corporation
Susquehanna International
Citadel Advisors
Northern Trust

View all funds holding Immix Biopharma